Novavax COVID-19 vaccination licensed for U.S. teenagers

novavax-covid-19-vaccination-licensed-for-us.-teenagers

The Food as well as Drug Administration licensed Novavax Inc.’s NVAX, -2.58% COVID-19 vaccination for usage in U.S. teens on Friday. Novavax’s recombinant protein-based vaccination makes use of various modern technology than the mRNA shots established by Moderna Inc. MRNA, -2.60% and also BioNTech SE BNTX, +0.21%, as well as obtained an emergency-use consent by the FDA for grownups in July The vaccination still needs a plan referral for usage by the Centers for Disease Control, which adhered to the FDA by regarding a week when licensing the Novavax shot for grownups Novavax shares ticked 0.6% greater in late trading Friday, after the news; the supply has decreased almost 75% thus far this year, as the S&P 500 index SPX, -1.29% has actually gone down 11.8%.

Source: Marketwatch

Related Posts